Industry: Pharmaceuticals, Biotechnology
Applied NeuroSolutions, Inc. (OTC BB: APNS) is developing novel therapeutic targets for the treatment of, and diagnostics for the detection of, Alzheimer’s disease. The company’s technology is based on discoveries originating from the Albert Einstein College of Medicine. Applied NeuroSolutions has developed a cerebrospinal fluid (CSF) test to detect early-stage Alzheimer’s disease with an 85%-95% accuracy in more than 3,500 patient samples. There are approximately 2 million new patients annually worldwide who are candidates for an AD CSF diagnostic test, according to the research firm Datamonitor. The company is also developing a blood serum-based screening test, as well as novel therapeutic targets for treatment of ( www.appliedneurosolutions.com )
Applied NeuroSolutions , Inc.
50 Lakeview Pkwy Suite 111
Vernon Hills, Illinois 60061
USA
Tel: (847) 573-8000
Fax: (847) 573-8030